CYTOREX Trademark

Trademark Overview


On Saturday, September 12, 2020, a trademark application was filed for CYTOREX with the United States Patent and Trademark Office. The USPTO has given the CYTOREX trademark a serial number of 90176507. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Cytorex Bioscoences, Inc.. The CYTOREX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes
cytorex

General Information


Serial Number90176507
Word MarkCYTOREX
Filing DateSaturday, September 12, 2020
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6354386
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements


Goods and ServicesMedicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2020
Primary Code005
First Use Anywhere DateMonday, April 10, 2000
First Use In Commerce DateMonday, April 10, 2000

Trademark Owner History


Party NameCytorex Bioscoences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDavie, FL 33331

Party NameCytorex Bioscoences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDavie, FL 33331

Party NameCytorex Bioscoences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDavie, FL 33331

Trademark Events


Event DateEvent Description
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 25, 2021EXAMINER'S AMENDMENT ENTERED
Monday, January 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 25, 2021EXAMINERS AMENDMENT E-MAILED
Monday, January 25, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, January 25, 2021ASSIGNED TO EXAMINER
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, September 16, 2020NEW APPLICATION ENTERED IN TRAM